logo-loader

Biotech Capital shares double in a week

Published: 17:30 07 Aug 2014 AEST

au_market_wrap_358x260_53e2f0c75b916

Biotech Capital (ASX:BTC) shares have jumped to as high as $0.063 so far this month, from just $0.026 on the last day of July.

Shares in the company are currently trading at $0.055 and a market cap of around $4 million.

Interest in the stock has been climbing since Domenic Carosa, a high profile technology investor, took a position in March.

Then on the 1st August, BTC appointed Dr Richard Treagus as its chairman.

Dr Treagus is a physician and entrepreneur, with over 20 years’ experience in the international pharmaceutical and biotechnology industry.

Richard served as Chief Executive of Acrux (ASX: ACR) until 2012, and is currently a director of QRxPharma (ASX: QRX), and Executive Chairman of Neuren Pharmaceuticals (ASX Code:NEU).



Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

6 hours, 59 minutes ago